Overcoming multiple drug resistance mechanisms in medulloblastoma

INTRODUCTION: Medulloblastoma (MB) is the most common malignant paediatric brain tumour. Recurrence and progression of disease occurs in 15-20% of standard risk and 30-40% of high risk patients. We analysed whether circumvention of chemoresistance pathways (drug export, DNA repair and apoptotic inhi...

Descripción completa

Detalles Bibliográficos
Autores principales: Othman, Ramadhan T, Kimishi, Ioanna, Bradshaw, Tracey D, Storer, Lisa CD, Korshunov, Andrey, Pfister, Stefan M, Grundy, Richard G, Kerr, Ian D, Coyle, Beth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4229867/
https://www.ncbi.nlm.nih.gov/pubmed/24887326
http://dx.doi.org/10.1186/2051-5960-2-57

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4229867/
https://www.ncbi.nlm.nih.gov/pubmed/24887326
http://dx.doi.org/10.1186/2051-5960-2-57

Ejemplares similares